All News

Zimmer Biomet Announces FDA Clearance and First Surgical Case of the Persona® Trabecular Metal™ Tibia

WARSAW, Ind., April 16, 2018 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced the completion of the first surgical case utilizing its Persona® Trabecular Metal™ (TM) Tibia by Dr. Richard Moore, Boise, Idaho on March 20, 2018. The Persona Trabecular Metal Tibia received 510(k) clearance from […]

Global Knee Replacement Market Analysis 2018-2024: Key Players are Zimmer Biomet, Stryker, Smith & Nephew, Johnson & Johnson – ResearchAndMarkets.com

April 16, 2018 DUBLIN–(BUSINESS WIRE)–The “Knee Replacement Market, Global Analysis, by Products, by Regions and Companies” report has been added to ResearchAndMarkets.com’s offering. Knee Replacement Market Globally is anticipated to exceed US$ 13 Billion by the year 2024, experiencing a significant growth over the forecast period. Knee Replacement consists of tools or system which is used for the diagnosis […]

Ceterix Orthopaedics Announces FDA Clearance of the NovoStitch Pro Meniscal Repair System

April 16, 2018 FREMONT, Calif.–(BUSINESS WIRE)–Ceterix® Orthopaedics, Inc., a leader in the development of cutting-edge surgical tools for orthopaedic surgeons, today announced U.S. Food and Drug Administration (FDA) clearance of the company’s NovoStitch® Pro Meniscal Repair System. This next-generation meniscal repair system is a significant product evolution, offering enhanced technical features to improve the ease of use […]

Two Data Presentations Highlight the Unique Potential of Spineology’s Duo™ Implant

April 16, 2018 ST. PAUL, Minn.–(BUSINESS WIRE)–Spineology Inc., an innovator in anatomy-conserving spine surgery, is excited to announce that two laboratory studies relating to the Spineology Duo™ Lumbar Interbody Fusion System were presented at the recent annual meeting of the International Society for the Advancement of Spine Surgery (ISASS) in Toronto, Canada. The Duo implant […]

K2M Group Holdings, Inc. to Release First Quarter of Fiscal Year 2018 Financial Results on May 1, 2018

LEESBURG, Va., April 13, 2018 (GLOBE NEWSWIRE) — K2M Group Holdings, Inc. (NASDAQ:KTWO) (the “Company” or “K2M”), a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional Total Body Balance™, today announced that first quarter of fiscal year 2018 financial results will be released after the market close on May 1, […]

Conventus Orthopaedics Appoints Jonathan Isenburg as Chief Financial Officer

MINNEAPOLIS, April 12, 2018 /PRNewswire/ — Conventus Orthopaedics, a medical device company revolutionizing fracture repair surgery, today announced the appointment of Jonathan Isenburg as its new Chief Financial Officer.  Mr. Isenburg brings corporate finance and executive experience to Conventus spanning both entrepreneurial and public company settings. Since April 2015, Mr. Isenburg served as CFO at Infraredx, Inc., where he led the […]

EOS imaging Reports 1st Quarter 2018 Revenue Growth of 34% and Full Year 2017 Results

April 11, 2018 PARIS–(BUSINESS WIRE)–Regulatory News: EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer of orthopedic medical imaging 2D / 3D, today announces its first quarter 2018 consolidated sales revenue and consolidated results for the full year ended December 31, 2017, as adopted by the Board of Directors on April 11, 2018. FIRST QUARTER 2018 […]

Lumbar Artificial Disc Replacement with the activL® Artificial Disc to be More Effective at Delaying the Progression of Adjacent-Level Disease which Spinal Fusion has been Found to Accelerate

CENTER VALLEY, Pa., April 12, 2018 /PRNewswire/ — Aesculap Implant Systems, LLC today announced the publication of “Progression of Adjacent-level Degeneration after Lumbar Total Disc Replacement: Results of a Post-hoc Analysis of Patients with Available Radiographs from a Prospective Study with 5-year Follow-up” in Spine.1 This is another significant milestone in Aesculap’s commitment to enhancing patient access to lumbar total […]

Spineology U.S. Clinical Trial for Interbody Fusion

April 12, 2018 ST. PAUL, Minn.–(BUSINESS WIRE)–Spineology Inc., an innovator in anatomy-conserving spine surgery, is excited to announce that John Chi, M.D., M.P.H, Associate Professor of Neurosurgery at Harvard Medical School and the Director of Neurosurgical Spinal Oncology at Brigham and Women’s Hospital in Boston MA, has presented the first 12-month outcomes data from Spineology’s […]

SpinalCyte Applies with FDA to Expand Human Clinical Trial of CybroCell™ Dermal Fibroblasts as Investigational New Drug (IND)

April 12, 2018 HOUSTON–(BUSINESS WIRE)–SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc nucleus using Human Dermal Fibroblasts, has filed an Investigational New Drug (IND) Application with the U.S. Food and Drug Administration (FDA) to expand its study of CybroCell Human Dermal Fibroblasts to treat degenerative disc disease.“The filing of […]

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1